A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

Barbaud, A.; Collet, E.; Milpied, B.; Assier, H.; Staumont, D.; Avenel-Audran, M.; Grange, A.; Amarger, S.; Girardin, P.; Guinnepain, M.T.; Truchetet, F.; Lasek, A.; Waton, J.; behalf of the Toxidermies group of the French Society of Dermatology, on

doi:10.1111/bjd.12125

Public

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

Published in British Journal of Dermatology • Nov 8, 2012

Authors:

A. Barbaud

E. Collet

B. Milpied

Abstract

BACKGROUND: Drug patch tests (PTs) can reproduce delayed hypersensitivity to drugs and entail a moderate re-exposure of patients to offending drugs. OBJECTIVES: To determine the value of PTs for identifying the responsible drug in severe cutaneous adverse drug reactions (SCARs) such as acute general...

Subject

Medicine

University hospital

Dermatology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!